Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

The Lancet . December 06, 2022

Enlaces

https://doi.org/10.1016/S2213-8587(22)00319-9

Artículos Relacionadas

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease

Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis

Review. Thyroid cancer

Approach to the Patient with Prolactinoma

The Use of Levothyroxine Absorption Tests in Clinical Practice

Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis

ESPEN practical guideline: Home parenteral nutrition

Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI)

Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study

Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

Agenda

Mayo 2023

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31	1	2	3	4

Top